JPRN-UMIN000020475已完成未知
Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer - Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine0 个研究点目标入组 24 人开始时间: 2016年1月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)other distant metastasis (2)allergy of gemcitabine or nab-paclitaxel (3)invasion of digestive tract (4)severe drug allergy (5)active infection (6)severe heart disease (7)severe complications(bowel obstruction, lung fibrosis, interstitial pneumonia, diabetes, renal failure, liver cirrhosis) (8)active synchronous cancer (9)peripheral neuropathy (10)uncontrollable ascites or pleural effusion (11)active gastrointestinal bleeding (12)severe diarrhea (13)mental disorder (14)pregnancy (15)no informed consent (16)inappropriate case (17)pulmonary fibrosis, interstitial pneumonia (18)history of abdominal irradiation (19)uncontrollable carcinomatous pain (20)Lung in the pulmonary field
研究者
相似试验
已完成
1 期
A phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic adenocarcinomanresectable locally advanced pancreatic adenocarcinomaJPRN-UMIN000012254Osaka Medical Center for Cancer and Cardiovascular Diseases Division of Hepatobiliary and Pancreatic Oncology54
已完成
1 期
Phase I study of chemotherapy with gemcitabine, CDDP and S-1 for the patients with unresectable biliary tract cancerJPRN-UMIN000008415Jikei University School of Medicine24
已完成
1 期
A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic CancerPancreatic CancerNCT02272738Osaka Medical Center for Cancer and Cardiovascular Diseases54
已完成
不适用
Prospective study of chemoradiotherapy with gemcitabine and S-1 for borderline resectable or unresectable pancreatic cancerpancreatic cancerJPRN-UMIN000011453Multicenter Clinical Study Group of Osaka50
尚未招募
1 期
Phase I study of definitive chemoradiotherapy with paclitaxel, CDDP and 5-FU (PCF-RT) for clinical stage IA-IIIC esophageal canceresophageal cancerJPRN-UMIN000028589Osaka international cancer institute24